EnGeneIC


EnGeneIC develops and commercializes the treatment of cancer through the targeted delivery of therapeutic agents directly to cancer cells.

Headquarters

Sydney, Australia

Employees

11-50

Links


Org chart

Collapse
Ilya Sedliarou
SVP, Antibody Science
Scott Pattison
VP, Translational & Clinical Operations
Nancy Mugridge
SVP, Pharma Alliances

Board & advisors

Mark Levitt
Board Member
Bryan Williams
Board Member
Bruce Stillman
Scientific Advisor
Ian Frazer
Scientific & Clinical Advisor
John Bacon
Advisor
Robert Frederick Seamark
Scientific Advisor


Offices